NICE has made six times more lung cancer treatment recommendations over the past ten years than in the previous decade

NICE

21 January 2025 - We have also recommended osimertinib for routine use on the NHS today.

The treatment landscape for lung cancer has changed considerably in the last decade, and survival rates have improved.

In the last 10 years NICE has made 48 positive recommendations for lung cancer treatments, 6 times more than in the previous decade.

Read NICE press release  

Michael Wonder

Posted by:

Michael Wonder